Cargando…

Ethical Hurdles in the Prioritization of Oncology Care

With finite resources, healthcare payers must make difficult choices regarding spending and the ethical distribution of funds. Here, we describe some of the ethical issues surrounding inequity in healthcare in nine major European countries, using cancer care as an example. To identify relevant studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Groot, Folkert, Capri, Stefano, Castanier, Jean-Claude, Cunningham, David, Flamion, Bruno, Flume, Mathias, Herholz, Harald, Levin, Lars-Åke, Solà-Morales, Oriol, Rupprecht, Christoph J., Shalet, Natalie, Walker, Andrew, Wong, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343076/ https://www.ncbi.nlm.nih.gov/pubmed/27766548 http://dx.doi.org/10.1007/s40258-016-0288-4

Ejemplares similares

Feasibility and attractiveness of indication value-based pricing in key EU countries
por: Flume, Mathias, et al.
Publicado: (2016)

Childhood immunisation in South Asia – overcoming the hurdles to progress
por: Hasman, Andreas, et al.
Publicado: (2016)

Approaches to manage ‘affordability’ of high budget impact medicines in key EU countries
por: Flume, Mathias, et al.
Publicado: (2018)

Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials
por: Ott, Mary A., et al.
Publicado: (2018)

Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
por: Paliard, Xavier, et al.
Publicado: (2019)

Challenging Perceptions About Oncology Product Pricing in Breast and Colorectal Cancer
por: Barron, Anthony, et al.
Publicado: (2016)

Implementing a mandatory COVID-19 vaccine: ethical challenges
por: Arora, A
Publicado: (2022)

Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology
por: Roosendaal, Jeroen, et al.
Publicado: (2020)

Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation
por: Burnouf, Thierry, et al.
Publicado: (2019)

Early Benefit Assessments in Oncology in Germany: How Can a Clinically Relevant Endpoint Not Be Relevant to Patients?
por: Ruof, Jörg, et al.
Publicado: (2015)

‘Longing’ for the Next Generation of Liquid Biopsy: The Diagnostic Potential of Long Cell-Free DNA in Oncology and Prenatal Testing
por: Yu, Stephanie C. Y., et al.
Publicado: (2023)

Collecting data on organizational structures of trauma centers: the CAFE web service
por: Brochhausen, Mathias, et al.
Publicado: (2020)

Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology?
por: Underhill, Hunter R.
Publicado: (2021)

A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy
por: Ingusci, Selene, et al.
Publicado: (2019)

Regulatory hurdles for genome editing: process- vs. product-based approaches in different regulatory contexts
por: Sprink, Thorben, et al.
Publicado: (2016)

First steps in identifying and addressing loneliness in the context of COVID-19
por: Cunningham, KB, et al.
Publicado: (2021)

Flooding in Nigeria, towards prioritizing mental health and psychosocial support
por: Oluka, Ejike Malachy, et al.
Publicado: (2022)

Has interest in smoking cessation declined during the COVID-19 pandemic?
por: Cunningham, JA, et al.
Publicado: (2023)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)

Controversial role of plant sterol esters in the management of hypercholesterolaemia
por: Weingärtner, Oliver, et al.
Publicado: (2009)

Interpreting troponin elevations: do we need multiple diagnoses?
por: Pierpont, Gordon L., et al.
Publicado: (2009)

Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human Pregnancy
por: Burton, G.J., et al.
Publicado: (2009)

Lipoprotein(a) as a cardiovascular risk factor: current status
por: Nordestgaard, Børge G., et al.
Publicado: (2010)

How does variability of immune system genes affect placentation?
por: Colucci, F., et al.
Publicado: (2011)

VARC consensus report: the FDA perspective(†)
por: Hillebrenner, Matthew G., et al.
Publicado: (2011)

Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses
por: Galiè, Nazzareno, et al.
Publicado: (2010)

Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis
por: Yousef, Zaheer, et al.
Publicado: (2013)

Potential Risks of Pharmacy Compounding
por: Gudeman, Jennifer, et al.
Publicado: (2013)

Extended Adjuvant Therapy with Imatinib in Patients with Gastrointestinal Stromal Tumors: Recommendations for Patient Selection, Risk Assessment, and Molecular Response Monitoring
por: Rutkowski, Piotr, et al.
Publicado: (2013)

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation
por: Kowey, Peter R., et al.
Publicado: (2012)

Confusion: Acetaminophen Dosing Changes Based on NO Evidence in Adults
por: Krenzelok, Edward P., et al.
Publicado: (2012)

Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?
por: Atzor, Sabine, et al.
Publicado: (2013)

Managing Healthcare Budgets in Times of Austerity: The Role of Program Budgeting and Marginal Analysis
por: Mitton, Craig, et al.
Publicado: (2014)

Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?
por: Navarese, Eliano Pio, et al.
Publicado: (2013)

An Integrated Approach to Defining Genetic and Environmental Determinants for Major Clinical Outcomes Involving Vitamin D
por: Berlanga-Taylor, Antonio J., et al.
Publicado: (2014)

Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery
por: Sousa-Uva, Miguel, et al.
Publicado: (2014)

Evolution of Drug Resistance in Tuberculosis: Recent Progress and Implications for Diagnosis and Therapy
por: Trauner, Andrej, et al.
Publicado: (2014)

Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine()
por: Nevin, Remington L.
Publicado: (2014)

Advancing the Field of Pharmaceutical Risk Minimization Through Application of Implementation Science Best Practices
por: Smith, Meredith Y., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6ik0e2kgogueqteafufvb2lkh1